|
CDNA | Caredx, Inc. |
|
|
CDNA | Caredx, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ 0.17 |
| Leverage | 20.15% |
| Market Cap | $ 2.4B |
| PE | 21.91 |
| Dividend Yield | 0.00% |
| Profit | $ 111.1m |
| Margin | 24.34% |
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.